May 26, 2023: 

Big Ten CRC lung cancer study to be presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting in Chicago. Cynthia Wei, MD of the Indiana University School of Medicine will present on the Big Ten CRC study titled, “Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC).”

BTCRC LUN16-081

Association of immune-related adverse events and efficacy outcomes in phase II trial of consolidation nivolumab plus ipilimumab or nivolumab alone after chemoradiation in patients with unresectable stage III non-small-cell lung cancer (NSCLC).  

Authors: Cynthia Wei, Sandra K. Althouse, Hirva Mamdani, Nasser H. Hanna, Greg Andrew Durm

Date: June 4, 2023 | Time: 8:00 AM – 11:00 AM | Location: Hall A

Session title: Lung Cancer – Non-Small Cell Local- Regional/Small Cell/Other Thoracic Cancers | Track: Lung Cancer | Sub track: Non-Small Cell Lung Cancer – Local-Regional Disease

Abstract: 8565 | Poster: 192  

Big Ten Cancer Research Consortium (Big Ten CRC) will have an exhibitors booth at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting. Visit Booth #28115 to talk with our highly qualified staff about managing oncology/hematology multi-center clinical trials.

Big Ten CRC will host in-person meetings for the Breast Cancer, Gastrointestinal, Thoracic, Melanoma and the Genitourinary Clinical Trial Working groups during ASCO 2023. If you would like to schedule time with an HCRN staff member during ASCO please reach out to Randy Dillinger at rdillinger@hoosiercancer.org. 

About the Big Ten Cancer Research Consortium: The Big Ten cancer centers have united to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team-research culture to drive science rapidly from ideas to treatment-changing paradigms. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to more than 9,800 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit www.bigten.org